2005
DOI: 10.1242/jeb.01594
|View full text |Cite
|
Sign up to set email alerts
|

Spider venom: enhancement of venom efficacy mediated by different synergistic strategies in Cupiennius salei

Abstract: Besides the power of the chelicerae, synergistic interactions between different components in the venom of Cupiennius salei ensure the hunting success of this spider. The main components of the venom were tested alone or in combination according to their physiological venom concentrations in Drosophila bioassays. The high K + ion content of the venom synergistically increases the insecticidal activity of the neurotoxins CSTX-1, CSTX-9 and CSTX-13 by 20% but does not influence the insecticidal effectiveness of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
26
0
3

Year Published

2007
2007
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(31 citation statements)
references
References 24 publications
2
26
0
3
Order By: Relevance
“…Here, 29-h-old erythrocytes (*1.7 9 10 8 cells/ml) were preincubated for 10 min at 25°C with different concentrations of tri-or penta-lysine. After incubation with 2.5 lM L-Cu1a for 1 h at 37°C haemolytic activity was measured as change in the absorbance at 541 nm Wullschleger et al 2005). In the case of insects, muscle cells as well as nerves are encircled by basement membranes rich in acidic proteins such as glutactin and papilin; glia cells are enriched with negatively charged arthrosides (Kramerova et al 2000;Olson et al 1990;Sickmann et al 1992).…”
Section: Effects Of L-cu1a On Different Human Cellsmentioning
confidence: 99%
See 1 more Smart Citation
“…Here, 29-h-old erythrocytes (*1.7 9 10 8 cells/ml) were preincubated for 10 min at 25°C with different concentrations of tri-or penta-lysine. After incubation with 2.5 lM L-Cu1a for 1 h at 37°C haemolytic activity was measured as change in the absorbance at 541 nm Wullschleger et al 2005). In the case of insects, muscle cells as well as nerves are encircled by basement membranes rich in acidic proteins such as glutactin and papilin; glia cells are enriched with negatively charged arthrosides (Kramerova et al 2000;Olson et al 1990;Sickmann et al 1992).…”
Section: Effects Of L-cu1a On Different Human Cellsmentioning
confidence: 99%
“…These a-helical peptides are highly cationic and exhibit strong cytolytic activities towards different prokaryotic cells and human erythrocytes (Kuhn-Nentwig et al 2002b). A dual role is proposed for cupiennins in that: (1) due to their cytolytic activity they synergistically enhance the activity of neurotoxins and other venom peptides Wullschleger et al 2004Wullschleger et al , 2005 and (2) they protect chelicerae and venom glands against microbial infections (Kuhn-Nentwig 2003). The best investigated cytolytic peptide, cupiennin 1a, is characterised by a helix-hinge-helix structure (Pukala et al 2007a), comparable to the structure of latarcin 2a (M-zodatoxin-Lt2a), a cytolytic peptide isolated from the venom of the central Asian spider Lachesana tarabaevi (Zodariidae) (Kozlov et al 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Venoms of a vast number of animal species represent complex mixtures of compounds (ions, biogenic amines, polyamines, polypeptide neurotoxins, cytolytic peptides, enzymes etc.) responsible for various effects [12-15]. Venoms can also be useful and valuable as pharmacological tools in drug research, as potential drug design templates and as therapeutic agents [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…1 B,C; Lotan et al, 1995;Lotan et al, 1996), and are a good example of a protein scaffold that has been recruited multiple times into venom systems (Fry et al, 2009 HMP3-Hma2.228615, SCP-ShK -Hma2.204028, ShKCLec -Hma2.206417, HMP1 -Hma2.217198, HMP2 -Hma2.214401, HMP4 -Hma2.228188. neural tissue, or by affecting many critical systems in parallel (Gutierrez et al, 2010, Wullschleger et al, 2005.…”
Section: Type III Secretory Phospholipase A2s (Pla2s)mentioning
confidence: 99%